Busulfan‐containing conditioning regimens in allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: A Taiwan observational study

BACKGROUND: Allogeneic stem cell transplantation (allo‐HSCT) is the ultimate cure for acute lymphoblastic leukemia (ALL). AIM: This study was performed to compare the outcomes of ALL patients receiving busulfan (Bu) with cyclophosphamide (Cy)‐based or total body irradiation (TBI)‐based regimen in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yu‐Hung, Tien, Feng‐Ming, Tsai, Cheng‐Hong, Huang, Huai‐Hsuan, Liu, Jia‐Hau, Liao, Xiu‐Wen, Tang, Jih‐Luh, Yao, Ming, Ko, Bor‐Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955073/
https://www.ncbi.nlm.nih.gov/pubmed/34196132
http://dx.doi.org/10.1002/cnr2.1488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955073/
https://www.ncbi.nlm.nih.gov/pubmed/34196132
http://dx.doi.org/10.1002/cnr2.1488

Ejemplares similares